Sisram Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	365.35	349.11	359.29	354.48	294.29
Revenue Growth (YoY)	4.65%	-2.83%	1.36%	20.45%	81.56%
Cost of Revenue	150.2	132.43	139.77	152.25	127.43
Gross Profit	215.14	216.68	219.53	202.23	166.86
Selling, General & Admin	165.73	165.09	159.44	128.76	100.71
Research & Development	16.86	15.94	18.03	18.02	15.59
Other Operating Expenses	5.53	7.98	4.03	10.04	7.8
Operating Expenses	188.12	189	181.5	156.82	124.1
Operating Income	27.03	27.68	38.03	45.41	42.76
Interest Expense	-3.25	-2.46	-2.06	-1.74	-2.01
Interest & Investment Income	0.96	0.79	0.6	0.61	0.54
Earnings From Equity Investments	0.21	0.03	-0.42	-0.52	-0.31
Currency Exchange Gain (Loss)	2.51	-	-	-	0.49
Other Non Operating Income (Expenses)	1.08	2.35	0.99	0.48	0.19
EBT Excluding Unusual Items	28.55	28.39	37.13	44.24	41.67
Gain (Loss) on Sale of Investments	-	4.15	-	-	-
Pretax Income	28.55	32.54	37.13	44.24	41.67
Income Tax Expense	3.55	3.78	4.23	4.16	9.15
Earnings From Continuing Operations	25.01	28.77	32.9	40.08	32.52
Minority Interest in Earnings	-5.99	-3.64	-1.4	0.09	-1.28
Net Income	19.02	25.13	31.5	40.17	31.25
Net Income to Common	19.02	25.13	31.5	40.17	31.25
Net Income Growth	-24.32%	-20.23%	-21.59%	28.57%	134.15%
Shares Outstanding (Basic)	468	468	467	466	453
Shares Outstanding (Diluted)	468	468	468	467	453
Shares Change (YoY)	-	-	0.34%	3.07%	2.42%
EPS (Basic)	0.04	0.05	0.07	0.09	0.07
EPS (Diluted)	0.04	0.05	0.07	0.09	0.07
EPS Growth	-24.25%	-20.36%	-21.84%	24.78%	128.63%
Free Cash Flow	6.8	30.33	35.37	17.29	29.41
Free Cash Flow Per Share	0.01	0.07	0.08	0.04	0.07
Dividend Per Share	0.012	0.016	0.020	0.022	0.020
Dividend Growth	-24.76%	-19.80%	-8.84%	10.20%	123.02%
Gross Margin	58.89%	62.07%	61.10%	57.05%	56.70%
Operating Margin	7.40%	7.93%	10.58%	12.81%	14.53%
Profit Margin	5.21%	7.20%	8.77%	11.33%	10.62%
Free Cash Flow Margin	1.86%	8.69%	9.84%	4.88%	9.99%
EBITDA	38.22	38.91	47.5	53.99	51.58
EBITDA Margin	10.46%	11.14%	13.22%	15.23%	17.53%
D&A For EBITDA	11.19	11.23	9.47	8.59	8.82
EBIT	27.03	27.68	38.03	45.41	42.76
EBIT Margin	7.40%	7.93%	10.58%	12.81%	14.53%
Effective Tax Rate	12.42%	11.60%	11.40%	9.41%	21.96%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.